EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Performance of a Combined Rapid Antigen Test for Detecting SARS‐CoV‐2, Influenza Virus, and Respiratory Syncytial Virus in Symptomatic Patients in Tertiary Care

Jakob Meyer, Rainer Gosert, Roland Bingisser, Christian H Nickel, Sarah Tschudin-Sutter, Karoline Leuzinger iD

Journal of Medical Virology · 2025-07 · 97 (7)

DOI: 10.1002/jmv.70493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 16.07.2025. Verfasst von Jakob Meyer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Medicine, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Respiratory Syncytial Virus Infections, Influenza, Human. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Clinical Virology unit, University Hospital Basel, Basel, Switzerland..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid antigen diagnostic tests (RDTs) can rapidly detect respiratory pathogens, allowing for the prompt initiation of infection control measures and the prevention of nosocomial spread within hospital settings. In this study, we prospectively evaluated the diagnostic performance of a combined RDT from AllTest Biotech for the simultaneous detection of SARS‐CoV‐2, influenza virus (IV‐A/B), and respiratory syncytial virus (RSV). We compared its diagnostic performance to the Xpert‐Xpress‐SARS‐CoV‐2/Flu/RSV molecular test using 100 naso‐oropharyngeal swabs (Ct‐values ≤ 35), collected from symptomatic patients with acute respiratory tract infections (RTIs) at our tertiary care hospital. The RDT showed a sensitivity of 60% (95%CI: 43.4%–74.7%) for SARS‐CoV‐2, with lower sensitivities for RSV at 60.0% (95%CI: 38.9%–78.2%) and IV‐A/B at 54.3% (95%CI: 36.9%–70.8%). Higher sensitivities of 100% were achieved for all three viruses in respiratory samples with higher viral loads (Ct‐values ≤ 25). The RDT demonstrated high specificity of > 99% for SARS‐CoV‐2, IV‐A/B, and RSV. In conclusion, the Alltest‐SARS‐CoV‐2/IV‐A + B/RSV RDT is effective for detecting SARS‐CoV‐2, IV‐A/B, and RSV in samples with high viral loads, but its sensitivity significantly declines at Ct‐values above 25. Therefore, negative RDT results should be confirmed with nucleic acid testing in symptomatic patients with RTIs to prevent severe consequences for clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Respiratory Syncytial Virus InfectionsInfluenza, HumanAntigens, ViralRespiratory Syncytial Virus, HumanOrthomyxoviridaeHumansSensitivity and SpecificityMaleProspective StudiesFemaleMiddle AgedAdultAgedTertiary Health CareTertiary Care CentersYoung AdultRespiratory Tract Infections

Stichwörter der Autor:innen

RATRDTRSVSARS‐CoV‐2influenzainfluenza virusrapid antigen testrapid diagnostic testrespiratory syncytial virusrespiratory tract infection

Substanzen

Antigens, Viral

Autor:innen und Institutionen

  • Emergency Medicine, University Hospital Basel, Basel, Switzerland.
  • Clinical Virology, University Hospital Basel, Basel, Switzerland.
  • Infectious Diseases, University Hospital Basel, Basel, Switzerland.
  • Department of Clinical Research, University Hospital Basel, Basel, Switzerland.

ORCID-Profile: Karoline Leuzinger

Förderung

  • This study was supported by the Clinical Virology unit, University Hospital Basel, Basel, Switzerland.

Zitieren

APA

Meyer, J., Gosert, R., Bingisser, R., Nickel, C. H., Tschudin-Sutter, S., & Leuzinger, K. (2025). Diagnostic Performance of a Combined Rapid Antigen Test for Detecting SARS‐CoV‐2, Influenza Virus, and Respiratory Syncytial Virus in Symptomatic Patients in Tertiary Care. Journal of Medical Virology, 97(7). https://doi.org/10.1002/jmv.70493

Vancouver

Meyer J, Gosert R, Bingisser R, Nickel CH, Tschudin-Sutter S, Leuzinger K. Diagnostic Performance of a Combined Rapid Antigen Test for Detecting SARS‐CoV‐2, Influenza Virus, and Respiratory Syncytial Virus in Symptomatic Patients in Tertiary Care. Journal of Medical Virology. 2025;97(7). doi:10.1002/jmv.70493

BibTeX
@article{Meyer2025,
  author = {Meyer, Jakob and Gosert, Rainer and Bingisser, Roland and Nickel, Christian H and Tschudin-Sutter, Sarah and Leuzinger, Karoline},
  title = {Diagnostic Performance of a Combined Rapid Antigen Test for Detecting SARS‐CoV‐2, Influenza Virus, and Respiratory Syncytial Virus in Symptomatic Patients in Tertiary Care},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {7},
  doi = {10.1002/jmv.70493}
}
Kostenlos starten →